Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Optimizing chemotherapy regimens for patients with early-stage breast cancer.

Clinical breast cancer - 1 Jan 2010

Dotan Efrat, Goldstein Lori J

Abstract excerpt

While moving toward a personalized treatment approach for early breast cancer, it is clear that treatment must be tailored specifically to the tumor's and patient's characteristics. Understanding the tumor's molecular signature and using validated prognostic and predictive tools can assist the on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anthracyclines
Share to Antineoplastic Combined Chemotherapy Protocols
Share to Diphosphonates

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, erbB-2

Share to Neoplasm Staging

Share to Plasminogen Activator Inhibitor 1

Share to Risk Assessment

Share to Urokinase-Type Plasminogen Activator

Source

Identifiers

PMID: 20587409
DOI: 10.3816/CBC.2010.s.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20587409-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Optimizing chemotherapy regimens for patients with early-stage breast cancer.PMID 20587409Read ↗

Personalized medicine: present and future of breast cancer management.Semantic proximity Read ↗

Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.Semantic proximity Read ↗

Breast cancer: An insight into its inflammatory, molecular, pathological and targeted facets with update on investigational drugsSemantic proximity Read ↗

Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer.Semantic proximity Read ↗

Pharmacogenomics of breast cancer therapy: An updateSemantic proximity Read ↗

How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategiesSemantic proximity Read ↗

Breast Molecular Profiling and Radiotherapy Considerations.Semantic proximity Read ↗

Pharmacogenomics in breast cancer: current trends and future directions.Semantic proximity Read ↗

Using molecular profiles to tailor treatment in breast cancer: are they ready for prime time?Semantic proximity Read ↗

Past, present, and future challenges in breast cancer treatment.Semantic proximity Read ↗

Identifying Breast Cancer Druggable Oncogenic Alterations: Lessons Learned and Future Targeted OptionsSemantic proximity Read ↗

Toxicity and Pharmacogenomic Biomarkers in Breast Cancer ChemotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.